SCHEMBL17875902

SCHEMBL17875902

c1cncc(-c2cc(-c3cccnc3)cc(-c3ccc4c(c3)-c3cc(-c5ccc6oc7ccccc7c6c5)ccc3COC4)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 11/20 0.41
CYP11B2 P19099 10/20 0.41
PGR P06401 1/20 0.41
TDP2 O95551 2/20 0.40
CYP1A2 P05177 6/20 0.38
CYP19A1 P11511 3/20 0.38
CYP17A1 P05093 1/20 0.38
PIM1 P11309 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PIK3CA P42336 1/20 0.37
LMNA P02545 2/20 0.36
MAPK1 P28482 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875865 0.96 CYP11B1 (0.41) CYP11B1CYP11B2PGRTDP2CYP1A2
SCHEMBL17875849 0.96 CYP11B1 (0.41) CYP11B1CYP11B2PGRTDP2CYP1A2
SCHEMBL17875898 0.93 CYP11B1 (0.41) CYP11B1CYP11B2PGRTDP2CYP1A2
SCHEMBL17875864 0.89 CYP11B1 (0.41) CYP11B1CYP11B2PGRTDP2CYP1A2
SCHEMBL17875835 0.89 CYP11B1 (0.41) CYP11B1CYP11B2PGRTDP2CYP1A2
SCHEMBL17875903 0.88 CYP11B1 (0.39) CYP11B1CYP11B2PGRTDP2CYP1A2
SCHEMBL17875789 0.88 CYP11B1 (0.40) CYP11B1CYP11B2PGRTDP2CYP1A2
SCHEMBL17875892 0.87 ALOX5 (0.46) CYP11B1CYP11B2PGRTDP2CYP1A2
SCHEMBL17875900 0.87 PLA2G2A (0.44) CYP1A2CYP19A1CYP3A4CYP2C19LMNA
SCHEMBL17876001 0.86 PGR (0.41) CYP11B1CYP11B2PGRTDP2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885PGR 1766/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885PGR 1766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.